| Kindred Hospice I 1141 East Main Street, Suite 208, Batesville, AR, 72501 | |
| (870) 376-5571 |
News Archive
Actelion Pharmaceuticals US, Inc., today announced that the U.S. Food and Drug Administration has approved the brand name VELETRI® for the company's epoprostenol for injection therapy. VELETRI has been commercially available since April 2010 as Epoprostenol for Injection for the treatment of moderate to severe pulmonary arterial hypertension (PAH) and PAH associated with the scleroderma spectrum of disease. Actelion plans to release VELETRI-labeled product by early fourth quarter of 2010.
By requiring commercial food establishments to replace trans fats with oils and spreads that are low in trans and saturated fats, New York City provides a good template for initiating public health measures to improve the quality of meals purchased outside the home, Tufts University Nutrition Scientist Alice H. Lichtenstein, DSc, writes in an editorial published July 17 in the Annals of Internal Medicine.
Today, Seattle Children's and Puget Sound Blood Center opened a new blood laboratory to serve Children's patients exclusively. Located within Seattle Children's main campus and staffed by Puget Sound Blood Center employees 24 hours every day of the year, the facility will bring the lab closer to the patient.
Intrexon Corporation, a privately held life sciences company focused on modular DNA control systems for biotherapeutics and other industry sectors, today announced the purchase of assets and operations of Avalon Pharmaceutical, Inc., a wholly-owned subsidiary of Clinical Data, Inc.
› Verified 3 days ago
| Name | Kindred Hospice I |
|---|---|
| Location | 1141 East Main Street, Suite 208, Batesville, Arkansas |
| Hospice ID | 041539 |
| Category | Freestanding Hospice |
| Ownership Type | Government - State |
| Profit Type | GEVERNMENT |
| SSA county code | 310 |
News Archive
Actelion Pharmaceuticals US, Inc., today announced that the U.S. Food and Drug Administration has approved the brand name VELETRI® for the company's epoprostenol for injection therapy. VELETRI has been commercially available since April 2010 as Epoprostenol for Injection for the treatment of moderate to severe pulmonary arterial hypertension (PAH) and PAH associated with the scleroderma spectrum of disease. Actelion plans to release VELETRI-labeled product by early fourth quarter of 2010.
By requiring commercial food establishments to replace trans fats with oils and spreads that are low in trans and saturated fats, New York City provides a good template for initiating public health measures to improve the quality of meals purchased outside the home, Tufts University Nutrition Scientist Alice H. Lichtenstein, DSc, writes in an editorial published July 17 in the Annals of Internal Medicine.
Today, Seattle Children's and Puget Sound Blood Center opened a new blood laboratory to serve Children's patients exclusively. Located within Seattle Children's main campus and staffed by Puget Sound Blood Center employees 24 hours every day of the year, the facility will bring the lab closer to the patient.
Intrexon Corporation, a privately held life sciences company focused on modular DNA control systems for biotherapeutics and other industry sectors, today announced the purchase of assets and operations of Avalon Pharmaceutical, Inc., a wholly-owned subsidiary of Clinical Data, Inc.
› Verified 3 days ago
| NPI Number | 1295185239 |
| Organization Name | Kah Development 4, Llc |
| Address | 1141 E Main St Batesville, Arkansas, 72501 |
| Phone Number | (870)376-5571 |
News Archive
Actelion Pharmaceuticals US, Inc., today announced that the U.S. Food and Drug Administration has approved the brand name VELETRI® for the company's epoprostenol for injection therapy. VELETRI has been commercially available since April 2010 as Epoprostenol for Injection for the treatment of moderate to severe pulmonary arterial hypertension (PAH) and PAH associated with the scleroderma spectrum of disease. Actelion plans to release VELETRI-labeled product by early fourth quarter of 2010.
By requiring commercial food establishments to replace trans fats with oils and spreads that are low in trans and saturated fats, New York City provides a good template for initiating public health measures to improve the quality of meals purchased outside the home, Tufts University Nutrition Scientist Alice H. Lichtenstein, DSc, writes in an editorial published July 17 in the Annals of Internal Medicine.
Today, Seattle Children's and Puget Sound Blood Center opened a new blood laboratory to serve Children's patients exclusively. Located within Seattle Children's main campus and staffed by Puget Sound Blood Center employees 24 hours every day of the year, the facility will bring the lab closer to the patient.
Intrexon Corporation, a privately held life sciences company focused on modular DNA control systems for biotherapeutics and other industry sectors, today announced the purchase of assets and operations of Avalon Pharmaceutical, Inc., a wholly-owned subsidiary of Clinical Data, Inc.
› Verified 3 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 100.0 | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 98.6 | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | 97.1 | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | 73.1 | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | 98.6 | 97.3 |
| Patients who got timely treatment for shortness of breath | 100.0 | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | 87.0 | 93.3 |
News Archive
Actelion Pharmaceuticals US, Inc., today announced that the U.S. Food and Drug Administration has approved the brand name VELETRI® for the company's epoprostenol for injection therapy. VELETRI has been commercially available since April 2010 as Epoprostenol for Injection for the treatment of moderate to severe pulmonary arterial hypertension (PAH) and PAH associated with the scleroderma spectrum of disease. Actelion plans to release VELETRI-labeled product by early fourth quarter of 2010.
By requiring commercial food establishments to replace trans fats with oils and spreads that are low in trans and saturated fats, New York City provides a good template for initiating public health measures to improve the quality of meals purchased outside the home, Tufts University Nutrition Scientist Alice H. Lichtenstein, DSc, writes in an editorial published July 17 in the Annals of Internal Medicine.
Today, Seattle Children's and Puget Sound Blood Center opened a new blood laboratory to serve Children's patients exclusively. Located within Seattle Children's main campus and staffed by Puget Sound Blood Center employees 24 hours every day of the year, the facility will bring the lab closer to the patient.
Intrexon Corporation, a privately held life sciences company focused on modular DNA control systems for biotherapeutics and other industry sectors, today announced the purchase of assets and operations of Avalon Pharmaceutical, Inc., a wholly-owned subsidiary of Clinical Data, Inc.
› Verified 3 days ago
| Home Health Aides | 2.5 |
| Counselors | 1 |
| Medical Social Workers | 1 |
| Registered Nurses | 3.5 |
| Other Personnel | 2.5 |
| Total Employees | 10.5 |
|---|
News Archive
Actelion Pharmaceuticals US, Inc., today announced that the U.S. Food and Drug Administration has approved the brand name VELETRI® for the company's epoprostenol for injection therapy. VELETRI has been commercially available since April 2010 as Epoprostenol for Injection for the treatment of moderate to severe pulmonary arterial hypertension (PAH) and PAH associated with the scleroderma spectrum of disease. Actelion plans to release VELETRI-labeled product by early fourth quarter of 2010.
By requiring commercial food establishments to replace trans fats with oils and spreads that are low in trans and saturated fats, New York City provides a good template for initiating public health measures to improve the quality of meals purchased outside the home, Tufts University Nutrition Scientist Alice H. Lichtenstein, DSc, writes in an editorial published July 17 in the Annals of Internal Medicine.
Today, Seattle Children's and Puget Sound Blood Center opened a new blood laboratory to serve Children's patients exclusively. Located within Seattle Children's main campus and staffed by Puget Sound Blood Center employees 24 hours every day of the year, the facility will bring the lab closer to the patient.
Intrexon Corporation, a privately held life sciences company focused on modular DNA control systems for biotherapeutics and other industry sectors, today announced the purchase of assets and operations of Avalon Pharmaceutical, Inc., a wholly-owned subsidiary of Clinical Data, Inc.
› Verified 3 days ago
| Others | 3 |
| Total Volunteers | 3 |
|---|
News Archive
Actelion Pharmaceuticals US, Inc., today announced that the U.S. Food and Drug Administration has approved the brand name VELETRI® for the company's epoprostenol for injection therapy. VELETRI has been commercially available since April 2010 as Epoprostenol for Injection for the treatment of moderate to severe pulmonary arterial hypertension (PAH) and PAH associated with the scleroderma spectrum of disease. Actelion plans to release VELETRI-labeled product by early fourth quarter of 2010.
By requiring commercial food establishments to replace trans fats with oils and spreads that are low in trans and saturated fats, New York City provides a good template for initiating public health measures to improve the quality of meals purchased outside the home, Tufts University Nutrition Scientist Alice H. Lichtenstein, DSc, writes in an editorial published July 17 in the Annals of Internal Medicine.
Today, Seattle Children's and Puget Sound Blood Center opened a new blood laboratory to serve Children's patients exclusively. Located within Seattle Children's main campus and staffed by Puget Sound Blood Center employees 24 hours every day of the year, the facility will bring the lab closer to the patient.
Intrexon Corporation, a privately held life sciences company focused on modular DNA control systems for biotherapeutics and other industry sectors, today announced the purchase of assets and operations of Avalon Pharmaceutical, Inc., a wholly-owned subsidiary of Clinical Data, Inc.
› Verified 3 days ago
| Kindred Hospice I Location: 1141 East Main Street, Suite 208, Batesville, Arkansas, 72501 Phone: (870) 376-5571 |
| Caring Hands Hospice Location: 2000 Harrison Street - Suite E, Batesville, Arkansas, 72501 Phone: (870) 376-5571 |
| Arkansas Hospice Inc Location: 2233 Harrison, Batesville, Arkansas, 72501 Phone: (870) 376-5571 |